Hunt H D, Pullen J K, Dick R F, Bluestone J A, Pease L R
Department of Immunology, Mayo Clinic, Rochester, MN 55905.
J Immunol. 1990 Sep 1;145(5):1456-62.
We have analyzed the functional significance of the four amino acid differences between the parental H-2Kb and mutant H-2Kbm8 glycoproteins. Six bm8 variants including single substitutions at residues 22, 23, 24, and 30 as well as paired substitutions at residues 23, 30 and 22, 24 were generated and transfected into L cells. Surface expression of these H-2Kb variants was analyzed using monoclonal antibodies which bind to well-defined H-2Kb epitopes. No alterations introduced into the conformational structure of H-2Kb by the amino acid substitutions were detected. The effect of these substitutions on CTL recognition was initially analyzed using the following bulk CTL: either H-2Kb anti-H-2Kbm8, H-2Kbm8 anti-H-2Kb, or third party anti-H-2Kb. The alloreactivity between H-2Kb and H-2Kbm8 is dominated by the amino acid substitution at residue 24 (Glu----Ser). The complete bm8 phenotype, however, also requires the additional substitution at residue 22 (Tyr----Phe). The H-2Kbm8 anti-Kb bulk CTL reacted with both variant H-2Kbm8 molecules containing single substitutions at amino acid positions 22 or 24 but not the variant molecule containing both substitutions. Further analysis using three individual H-2Kbm8 anti-Kb CTL clones indicated the complexity of the self Kbm8 phenotype. Clone 8B1.20 did not react to changes in residues 22 or 24. The 8B1.32 clone reacted with the change at residue 22 but not with the change at residue 24, although the 8B1.54 clone reacted with the change at residue 24 but not with the change at residue 22. The changes in residues 23 (Met----Ile) and/or 30 (Asp----Asn) did not impact significantly on the alloantigenic properties of Kbm8 as determined by both the bulk and cloned CTL populations. According to the three-dimensional class I structure the substitution at amino acid 24 is inaccessible to the TCR. The location of this substitution within the Ag recognition site implies that altered peptide binding, and not a disruption of MHC residues that interact with the TCR, is responsible for the alloreactivity between H-2Kb and H-2Kbm8.
我们分析了亲本H-2Kb与突变型H-2Kbm8糖蛋白之间四个氨基酸差异的功能意义。构建了六个bm8变体,包括在第22、23、24和30位残基处的单取代,以及在第23、30位和第22、24位残基处的双取代,并将其转染到L细胞中。使用与明确的H-2Kb表位结合的单克隆抗体分析了这些H-2Kb变体的表面表达。未检测到氨基酸取代对H-2Kb构象结构的改变。这些取代对CTL识别的影响最初使用以下大量CTL进行分析:H-2Kb抗H-2Kbm8、H-2Kbm8抗H-2Kb或第三方抗H-2Kb。H-2Kb与H-2Kbm8之间的同种异体反应性主要由第24位残基(Glu----Ser)的氨基酸取代决定。然而,完整的bm8表型还需要第22位残基(Tyr----Phe)的额外取代。H-2Kbm8抗Kb大量CTL与在氨基酸位置22或24处含有单取代的两种变体H-2Kbm8分子反应,但不与含有两种取代的变体分子反应。使用三个单独的H-2Kbm8抗Kb CTL克隆进行的进一步分析表明了自身Kbm8表型的复杂性。克隆8B1.20对第22或24位残基的变化无反应。8B1.32克隆与第22位残基的变化反应,但不与第24位残基的变化反应,尽管8B1.54克隆与第24位残基的变化反应,但不与第22位残基的变化反应。第23位残基(Met----Ile)和/或第30位残基(Asp----Asn)的变化对大量和克隆的CTL群体所确定的Kbm8的同种异体抗原特性没有显著影响。根据I类三维结构,第24位氨基酸的取代TCR无法接触到。该取代在Ag识别位点内的位置表明,改变的肽结合而非与TCR相互作用的MHC残基的破坏,是H-2Kb与H-2Kbm8之间同种异体反应性的原因。